LD-2 disclosure · 1st Quarter - Report
SPYRE THERAPEUTICS, INC.
Income$40Kfee reported
Client
- Name
- SPYRE THERAPEUTICS, INC.
- Description
- Biotechnology company focused on treatments for gastrointestinal and rheumatic diseases.
- Location
- Massachusetts · United States of America
Registrant
- Description
- Law firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Issues related to monoclonal antibody products.
LobbyistsBOBBY MCMILLIN · LUKE ALBERT
Covered position (LUKE ALBERT): Intern, Rep. Horn (2019)
TargetedSENATE · HOUSE OF REPRESENTATIVES
